The Five Dumbest Things on Wall Street This Week

Try Jim Cramer's Action Alerts PLUS
CLICK HERE NOW

The Five Dumbest Things on Wall Street: Feb. 29

02/29/08 - 06:28 AM EST

Marek Fuchs

2. Jarvik's Artificial Rower

PfizerPFE, we've missed you. Drug companies tend to provide plenty of dumbness, and Pfizer has been a stalwart, but had gone missing of late.

They're back. So where to start with this tale of free-form idiocy that took the form of now dearly departed commercials about a pill? The company set out to impress potential statin users by employing Dr. Robert Jarvik, the artificial heart pioneer, as their commercial spokesman and got accused of speaking falsely, but that wasn't the dumb part.

No, this huge drug company was forced to pull its big commercial campaign on Lipitor, the big cholesterol drug, because it was thought to be misleading in featuring Jarvik rowing a boat. Apparently, to make its shill look vibrant, Pfizer had to use a stunt double. You know how these nerdy medical sorts can be.

Dr. Jarvik supposedly cannot row an oar and chew gum at the same time. And, oh, by the way, he is also not technically a doctor -- at least one certified to practice --so making it seem like he is giving medical advice got a bit of a hairy eyeball from regulators, the fusspots. What could be next, filling out prescriptions with your Series 7? Puh-leez.

And now for the dumb part.

Pfizer sought to peddle a drug that is supposed to reduce the presence of an unseen substance so you can live a normal life ... with a guy most associated in the public consciousness still with a Dr. Seuss machine to substitute for the heart that kept Barney Clarke, a retired dentist, alive for a few extra, chained months.

Even someone not well versed in the field of advertising can conjure up better associations than this. But here is the association we are left with, after the intervention of Washington. The House Energy and Commerce Committee has, it was reported this week, asked the (count 'em) 10 advertising firms who worked on this stellar campaign to give up documents. About what, you ask? The use of body doubles.

Dumb-o-meter score: 88. Dr. Jarvik, you were getting paid over $1 million to peddle this drug. That would have covered a few rowing lessons, dude. Now, with a war still waging, Washington has to take their precious time from investigated Roger Clemens abscessed buttock cheek. Shame on you, sir.

At the time of publication, Fuchs had no positions in any of the stocks mentioned in this column.

Marek Fuchs was a stockbroker for Shearson Lehman Brothers and a money manager before becoming a journalist who wrote The New York Times' "County Lines" column for six years. He also did back-up beat coverage of The New York Knicks for the paper's Sports section for two seasons and covered other professional and collegiate sports. He has contributed frequently to many of the Times' other sections, including National, Metro, Escapes, Style, Real Estate, Arts & Leisure, Travel, Money & Business, Circuits and the Op-Ed Page. For his "Business Press Maven? column on how business and finance are covered by the media, Fuchs was named best business journalist critic in the nation by the Talking Biz website at The University of North Carolina School of Journalism and Mass Communication. Fuchs is a frequent speaker on the business media, in venues ranging from National Public Radio to the annual conference of the Society of American Business Editors and Writers. Fuchs appreciates your feedback; click here to send him an email.


Life & Money

The Five Dumbest Things on Wall Street This Week

Go To Section Home


02/27/08
Macy's Silence Speaks Volumes to Investors

When a public company stops issuing sales figures and guidance, take heed, even if those in the media don't.


02/25/08
Buy Signal: The Media Hate the Market

Fears of coming economic data and two reports trashing Goldman Sachs set a reliable tone.


02/23/08
Buffett and Gates Play Bridge -- Do You?

These two giants favor bridge, so why do most traders play poker?


02/22/08
Starbucks Layoffs Not as Grande as Reported

Hasty reporting of 600 job cuts missed an essential fact: the correct number.


05/19/08
Cramer on Top Searched Stocks: Yahoo!

Yahoo! is among the most searched stocks on TheStreet.com. Here's what Cramer had to say about the stock recently.


05/17/08
Jim Cramer's Best Blogs

Catch up on his thinking on the hottest topics of the past week.


04/26/08
Coming Week: Make or Break

Investors will have to deal with a Fed meeting and another flood of earnings and economic data.


05/19/08
Top Rocket Stocks: Ensco

Ensco International and Echelon have the potential to move higher in coming days.


04/28/08
Monday's Analysts' Upgrades, Downgrades

See who made what calls.


05/19/08
Telecom Giants See a Savior in Video

The addition of video is helping telecom companies compete against cable and satellite companies.


05/19/08
Contract Expiration Tempers Oil's Rise

The June West Texas Intermediate contract reflects selling pressure ahead of Tuesday's expiration. But stocks in the sector are generally trading higher.


05/19/08
Analysts' Upgrades, Downgrades: Amazon

See who made what calls.


Your Recent Quotes: Quote Up0 | Quote Down0
Dow S&P 500 NASDAQ
Oil*
Gold
10 Yr
0.00%
%
%
%
Data delayed 20 min
Sign up for our FREE newsletters now.

Keep on top of the market and the critical information you need to make more profitable investing decisions.

  • Cramer's Daily Booyah!
  • Before the Bell

Privacy Policy

See All Free Newsletters

Premium Stock Ideas